Compared with less invasive surgeries, this procedure may subject patients to greater risk, study finds.

Fortunately, for the most part, the resultant negative outcomes seem to retract following at least 12 months of anti-VEGF treatment, research suggests.

Clinicians should maintain high suspicion when evaluating these patients.

Enforcing new protocols would ward off exposure-related complications and subsequent ocular morbidity.

Though rare in these patients, double vision is often accompanied by serious symptoms worth investigating.